Pride Health, Asia’s pioneering LGBTQ+ digital healthcare platform, has successfully raised US$300,000 in a pre-seed funding round. The investment, supported by A2D Ventures, Enterprise Singapore, First Move, and depa’s Digital Startup Fund (S2), will enable the Thailand-based company to expand its inclusive healthcare services across Asia, focusing on stigma-free and personalised care for LGBTQ+ individuals.
The platform addresses significant healthcare inequities faced by over 70% of LGBTQ+ individuals in Asia, who encounter barriers due to stigma and a lack of trained providers. Pride Health integrates telehealth consultations, digital prescriptions, and AI-driven personalisation to offer preventive, mental, sexual, and gender-affirming healthcare. Since its launch in March 2025, the platform has onboarded over 1,800 users, achieving a 54% repeat rate, which highlights the trust and demand within the community.
Pride Health plans to expand its services beyond Thailand into Singapore, Malaysia, Hong Kong, Vietnam, and the Philippines through strategic clinical and community partnerships. The funding will also support the development of new clinical verticals, including gender-affirming care and preventive medicine, alongside AI and automation infrastructure enhancements.
Bruce Li, Co-Founder and CEO of Pride Health, emphasised the importance of accessible healthcare, stating, “Everyone deserves the right to their unique healthcare needs. Across Asia, too many LGBTQ+ people are still being denied that right.” The company’s mission is to ensure that everyone can access judgement-free and innovative healthcare.
With this strategic backing, Pride Health is poised to revolutionise the healthcare landscape for LGBTQ+ communities across Asia, setting a precedent for inclusive and personalised care.
